 |
 |
|
 |
 |
News from SGC
Posted on Wednesday 4th of February 2015
This morning at MaRS Discovery District, Merck confirmed its commitment to research and innovation with a $7.5 million contribution to the Structural Genomics Consortium Toronto. (From left to right) Dr. Ronan O'Hagan, Dr. Aled Edwards, The Honourable Reza Moridi, Mr. Chirfi Guindo and Ms. Jennifer Chan. (CNW Group/Merck)
Posted on Monday 15th of December 2014
TORONTO, ON (December 9, 2014) — Dr. Aled Edwards, co-founder and CEO of Structural Genomics Consortium (SGC), has been elected a Senior Ashoka Fellow.
Posted on Monday 24th of November 2014
$2 million grant from the Bill & Melinda Gates Foundation furthers existing research on malaria and TB
Toronto, ON --Almost $2 million is being invested by the Bill & Melinda Gates Foundation to help fight major parasitic diseases of the developing world.
Posted on Tuesday 11th of November 2014
As part of the International Year of Crystallography, the NDM at the University of Oxford has produced a four part documentary explaining how the field of structural biology has developed over the past 100 years, Oxford’s involvement in that development, and where we go from here.
Posted on Wednesday 29th of October 2014
The SGC-CHDI open access patent-free partnership for Huntington’s disease research has been selected as a featured Innovator to present on November 17th at the 6th annual Partnering for Cures meeting in New York City, NY. The conference will bring together nearly 1,000 medical research leaders, investors and decision-makers to forge the collaborations needed to speed and improve outcomes-driven R&D.
Posted on Tuesday 28th of October 2014
2014 is the International Year of Crystallography and to celebrate this event NDM has produced a series of short films.
‘Revolutionary Biology’: Revolutionary Biology shows how the field of structural biology has developed over the past 100 years, Oxford’s involvement in that development, and where we go from here.
Posted on Monday 27th of October 2014
SGC Toronto will hold a free workshop ‘EZH2 Inhibitors: Target Validation through Chemical Biology’, on February 9th, 2015 at the Princess Margaret Cancer Centre in Toronto, ON.
The goal of this event is to share practical knowledge gained using EZH2 inhibitors in various cellular and in vivo systems. In the spirit of sharing information, this workshop will be highly interactive.
The workshop will feature presentations from scientists in academia and industry. Participants are encouraged to submit posters from which 3-4 will be chosen for short oral presentations.
Posted on Monday 13th of October 2014
Every year, about 60 DPhil students start a life changing experience in the Nuffield Department of Medicine in Oxford.
Sarah Dixon-Clarke, born in the UK, joined the University of Oxford in 2011 after studying Biological Sciences and Biochemistry at the University of St Andrews. Sarah is affiliated with University College and works on structure-function analysis of the extended cyclin-dependent kinase family under the supervision of Dr Alex Bullock.
Sarah Dixon-Clarke, born in the UK, joined the University of Oxford in 2011 after studying Biological Sciences and Biochemistry at the University of St Andrews. Sarah is affiliated with University College and works on structure-function analysis of the extended cyclin-dependent kinase family under the supervision of Dr Alex Bullock.
Posted on Thursday 2nd of October 2014
"Making pharmaceutical research more open could shave years off the time it takes to bring a new drug to market".
SGC's commitment to accelerating drug discovery is profiled by John Lorinc in the University of Toronto Magazine.
Pages
